EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China

Ruoyu Deng, Lin Wang, Jialing Lv, Feineng Liu, Tengfei Zhang, Chunyan Li, Chongxin Li, Zhijun Zhang, Huahua Zhou, Wen Zhang, Chao Zhang

Chinese Clinical Oncology · 2025

DOI: 10.21037/cco-25-43 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Chinese Clinical Oncology, 2025. Verfasst von Ruoyu Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Qujing First People's Hospital/Kunming Medical University Affiliated Qujing Hospital, Qujing, China. Hauptthemen laut MEDLINE: Afatinib, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfatinibCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesChinaMutationErbB ReceptorsAgedAdult

Stichwörter der Autor:innen

G719X + S768INon-small cell lung cancer (NSCLC)afatinibepidermal growth factor receptor (EGFR)

Substanzen

AfatinibErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Oncology, Qujing First People's Hospital/Kunming Medical University Affiliated Qujing Hospital, Qujing, China.

Zitieren

APA

Deng, R., Wang, L., Lv, J., Liu, F., Zhang, T., Li, C., Li, C., Zhang, Z., Zhou, H., Zhang, W., & Zhang, C. (2025). Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China. Chinese Clinical Oncology. https://doi.org/10.21037/cco-25-43

Vancouver

Deng R, Wang L, Lv J, Liu F, Zhang T, Li C, et al. Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China. Chinese Clinical Oncology. 2025. doi:10.21037/cco-25-43

BibTeX
@article{Deng2025,
  author = {Deng, Ruoyu and Wang, Lin and Lv, Jialing and Liu, Feineng and Zhang, Tengfei and Li, Chunyan and Li, Chongxin and Zhang, Zhijun and Zhou, Huahua and Zhang, Wen and Zhang, Chao},
  title = {Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China},
  journal = {Chinese Clinical Oncology},
  year = {2025},
  doi = {10.21037/cco-25-43}
}
Kostenlos starten →